Advancements in Gene Therapy for Hemophilia B

This chapter delves into the Bean Gene 2 trial from the New England Journal of Medicine, which investigates gene therapy applications for hemophilia B. It highlights the trial's promising findings on reduced bleeding episodes and discusses the broader implications of gene therapy advancements for chronic conditions and emergency care providers.